| The relationship between circulating endothelin-1, soluble fms-like tyrosine kinase-1 and soluble endoglin in preeclampsia PK Aggarwal, N Chandel, V Jain, V Jha Journal of human hypertension 26 (4), 236-241, 2012 | 148 | 2012 |
| FAT1 mutations cause a glomerulotubular nephropathy HY Gee, CE Sadowski, PK Aggarwal, JD Porath, TA Yakulov, M Schueler, ... Nature communications 7 (1), 10822, 2016 | 121 | 2016 |
| Low urinary placental growth factor is a marker of pre-eclampsia PK Aggarwal, V Jain, V Sakhuja, SA Karumanchi, V Jha Kidney international 69 (3), 621-624, 2006 | 101 | 2006 |
| Endothelial nitric oxide synthase, angiotensin-converting enzyme and angiotensinogen gene polymorphisms in hypertensive disorders of pregnancy PK Aggarwal, V Jain, V Jha Hypertension Research 33 (5), 473-477, 2010 | 89 | 2010 |
| Acute Podocyte Vascular Endothelial Growth Factor (VEGF-A) Knockdown Disrupts alphaVbeta3 Integrin Signaling in the Glomerulus D Veron, G Villegas, PK Aggarwal, C Bertuccio, J Jimenez, H Velazquez, ... PloS one 7 (7), e40589, 2012 | 79 | 2012 |
| Vascular endothelial growth factor receptor 2 direct interaction with nephrin links VEGF-A signals to actin in kidney podocytes C Bertuccio, D Veron, PK Aggarwal, L Holzman, A Tufro Journal of Biological Chemistry 286 (46), 39933-39944, 2011 | 79 | 2011 |
| Semaphorin3a promotes advanced diabetic nephropathy PK Aggarwal, D Veron, DB Thomas, D Siegel, G Moeckel, M Kashgarian, ... Diabetes 64 (5), 1743-1759, 2015 | 73 | 2015 |
| Iron status, inflammation and hepcidin in ESRD patients: The confounding role of intravenous iron therapy A Jairam, R Das, PK Aggarwal, HS Kohli, KL Gupta, V Sakhuja, V Jha Indian Journal of Nephrology 20 (3), 125-131, 2010 | 72 | 2010 |
| Purification and characterization of Enterobacter sakazakii enterotoxin M Raghav, PK Aggarwal Canadian journal of microbiology 53 (6), 750-755, 2007 | 61 | 2007 |
| High prevalence of vitamin D deficiency in north Indian adults is exacerbated in those with chronic kidney disease Z Jabbar, PK Aggarwal, N Chandel, HS Kohli, KL Gupta, V Sakhuja, V Jha Nephrology 14 (3), 345-349, 2009 | 48 | 2009 |
| CYP3A5* 1/* 3 genotype influences the blood concentration of tacrolimus in response to metabolic inhibition by ketoconazole N Chandel, PK Aggarwal, M Minz, V Sakhuja, KK Kohli, V Jha Pharmacogenetics and genomics 19 (6), 458-463, 2009 | 37 | 2009 |
| Podocyte-Specific VEGF-A Gain of Function Induces Nodular Glomerulosclerosis in eNOS Null Mice. D Veron, PK Aggarwal, H Velazquez, M Kashgarian, ... J Am Soc Nephrol., 2014 | 35 | 2014 |
| Maternal EDN1 G5665T polymorphism influences circulating endothelin-1 levels and plays a role in determination of preeclampsia phenotype PK Aggarwal, V Jain, R Srinivasan, V Jha Journal of hypertension 27 (10), 2044-2050, 2009 | 35 | 2009 |
| Excess podocyte semaphorin-3A leads to glomerular disease involving plexinA1–nephrin interaction KJ Reidy, PK Aggarwal, JJ Jimenez, DB Thomas, D Veron, A Tufro The American journal of pathology 183 (4), 1156-1168, 2013 | 29 | 2013 |
| Noninvasive assessment of bone health in Indian patients with chronic kidney disease Z Jabbar, PK Aggarwal, N Chandel, N Khandelwal, HS Kohli, V Sakhuja, ... Indian journal of nephrology 23 (3), 161-167, 2013 | 23 | 2013 |
| Renin-angiotensin-aldosterone system in the pathogenesis of pregnancy-induced hypertension R Świątkowska-Stodulska, P Kmieć, K Stefańska, K Sworczak Experimental and Clinical Endocrinology & Diabetes 126 (06), 362-366, 2018 | 18 | 2018 |
| ffrench-Constant C HY Gee, CE Sadowski, PK Aggarwal, JD Porath, TA Yakulov, M Schueler, ... Allen N, McNeill, H, Büscher R, Kyrieleis H, Wallot M, Gaspert A, Kistler T …, 2016 | 18 | 2016 |
| Understanding metabolic changes in aging bone marrow KM Connor, Y Hsu, PK Aggarwal, S Capone, AR Colombo, G Ramsingh Experimental Hematology & Oncology 7, 1-11, 2018 | 15 | 2018 |
| Mould contamination from dairy and farm environment. PK Aggarwal, RA Srinivasan | 12 | 1981 |
| Podocyte VEGF-A Knockdown Induces Diffuse Glomerulosclerosis in Diabetic and in eNOS Knockout Mice D Veron, PK Aggarwal, Q Li, G Moeckel, M Kashgarian, A Tufro Frontiers in Pharmacology 12, 788886, 2022 | 10 | 2022 |
Vivekanand JhaExecutive Director, George Institute for Global Health, India; Chair of Global Kidney HealthVerified email at georgeinstitute.org.in
